One of the missions at the CIB Margarita Salas-CSIC consists in making available to society the knowledge and the research results generated in our research center. Thus, we aim to convert our basic research findings into tangible applications, either through the generation and licensing of intellectual property and/or through the generation of spin-off companies. Currently, the CIB Margarita Salas has 9 EBTs considered CSIC spin-offs: Secugen, Protein alternatives, Lifesequencing (now ADM-Lifesequencing), Ankar Pharma, Abvance Biotech, Arrays for Cell Nanodevices (A4CELL), AItenea Biotech, HelpRare and Plasticentropy. Spin-off ProRetina Therapeutics closed in 2019 after 12 years of activity, and Microbial Biosystems ceased in 2022.
